Related Experiment Video
Updated: Dec 31, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions
Nicolas Doisne1,2,3, Victor Waldmann4, Alban Redheuil1,3,5
1Faculté de Médecine, Sorbonne Université, Paris, France.
Abstract:
Recently, four SCN5A mutations have been associated with Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC), a rare cardiac syndrome combining polymorphic ventricular arrhythmia with dilated cardiomyopathy (DCM). Here, we identified a novel heterozygous mutation in SCN5A (c.611C>A, pAla204Glu) in a young woman presenting with polymorphic premature ventricular contractions (PVCs) and DCM. After failure of antiarrhythmic drugs and an attempt of radiofrequency catheter ablation showing three exit-sites of PVCs, all with presystolic Purkinje potentials, a treatment by hydroquinidine was tried, leading to an immediate and spectacular disappearance of all PVCs and normalization of cardiac function. Electrophysiological studies showed that Nav 1.5-A204E mutant channels exhibited a significant leftward shift of 8 mV of the activation curve, leading to a larger hyperpolarized window current when compared to wild-type. Action potential modeling using Purkinje fiber and ventricular cell models predicted an arrhythmogenic effect predominant in Purkinje fibers for the A204E mutation. Comparison with other MEPPC-associated Nav 1.5 mutations revealed a common electrophysiological pattern of abnormal voltage-dependence of activation leading to a larger hyperpolarized window current as a shared biophysical mechanism of this syndrome. These features of the mutant sodium channels are likely to be responsible for the hyperexcitability of the fascicular-Purkinje system observed in patients with MEPPC.
Insights
A novel SCN5A mutation causes Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC), a condition linked to polymorphic ventricular arrhythmia and dilated cardiomyopathy. Hydroquinidine effectively treated a patient, highlighting a shared channelopathy mechanism.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Multifocal Ectopic Purkinje-related Premature Contractions (MEPPC) is a rare cardiac syndrome.
- MEPPC is characterized by polymorphic ventricular arrhythmia and dilated cardiomyopathy (DCM).
- Four SCN5A mutations have been previously linked to MEPPC.
Purpose of the Study:
- To identify the genetic cause of MEPPC in a young woman with polymorphic premature ventricular contractions (PVCs) and DCM.
- To investigate the functional consequences of a novel SCN5A mutation.
- To explore the underlying biophysical mechanism of MEPPC.
Main Methods:
- Genetic sequencing to identify SCN5A mutations.
- Electrophysiological studies of mutant Nav1.5 channels.
- Action potential modeling of Purkinje fibers and ventricular cells.
- Clinical assessment and treatment of the patient.
Main Results:
- A novel heterozygous SCN5A mutation (c.611C>A, pAla204Glu) was identified.
- The Nav1.5-A204E mutation caused a significant leftward shift in the activation curve, increasing hyperpolarized window current.
- Hydroquinidine treatment led to the disappearance of PVCs and normalization of cardiac function.
- Modeling predicted an arrhythmogenic effect predominantly in Purkinje fibers.
Conclusions:
- The pAla204Glu mutation in SCN5A is a novel cause of MEPPC.
- Abnormal voltage-dependence of activation leading to increased hyperpolarized window current is a shared mechanism in MEPPC.
- This channelopathy explains the hyperexcitability of the fascicular-Purkinje system in MEPPC patients.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Single Nucleotide Polymorphisms-SNPs
Point and Frameshift Mutations
Cardiomyopathy IV: Restrictive Cardiomyopathy